NewClin develops a data-driven and AI-powered game-changing SaaS B2B platform to automatically contextualize patients' health data with their non-medical (social, behavioral, environmental) determinants of health. It allows the production of new patient-, cohort- and population-related predictive and prognostic markers, including a unique patient's Health Determinome, paving the way for precision interventions and precision prevention. Our ambition is to transform decisions from industry, healthcare providers, researchers, and payors in order to decrease the cost and increase the performance or healthcare and clinical research and improve and/or prolong patients' lives. Our current focus is oncology, but our solution is applicable to other therapeutic fields.